Sign in

CIK 0001781174

  • Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
825125532
Phone
+1 617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
  1. 4 Shares withheld for taxes Chief Legal Officer gave up 558 shares (to pay taxes)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Shares withheld for taxes President and CEO gave up 14,265 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Accounting Officer gave up 116 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Legal Officer gave up 217 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Development Officer gave up 471 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Operating Officer gave up 723 shares (to pay taxes)
  14. 4 Shares withheld for taxes President and CEO gave up 1,881 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Legal Officer gave up 659 shares (to pay taxes)
  16. 4 Open-market buy President and CEO bought 49,000 shares at $1.68 ($82,124)
  17. 4 Open-market buy Chief Financial Officer bought 8,832 shares at $1.70 ($14,999)
  18. 4 Open-market buy Chief Operating Officer bought 10,000 shares at $1.72 ($17,218)
  19. 4 Shares withheld for taxes President and CEO gave up 19,904 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Accounting Officer gave up 99 shares (to pay taxes)

Page 3 of 11 · 206 filings